Hallet, Julie
Davis, Laura E.
Mahar, Alyson L.
Liu, Ying
Zuk, Victoria
Gupta, Vaibhav
Earle, Craig C.
Coburn, Natalie G.
Article History
Received: 20 May 2019
Accepted: 3 October 2019
First Online: 18 October 2019
Compliance with ethical standards
:
: Julie Hallet has received speaking honoraria from Ipsen Biopharmaceuticals Canada and Novartis Oncology. Natalie Coburn receives salary support from Cancer Care Ontario as the Clinical Lead of Patient Reported Outcomes and Symptom Management. Laura Davis declares that she has not conflict of interest. Alyson Mahar declares that she has not conflict of interest. Ying Liu declares that she has not conflict of interest. Vaihbav Gupta declares that he has not conflict of interest. Craig Earle declares that he has not conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was waived by the Sunnybrook Health Sciences Centre Research Ethics Board, for the conduct of population-based analysis.
Free to read: This content has been made available to all.